FTD
Clinical trials for FTD explained in plain language.
Never miss a new study
Get alerted when new FTD trials appear
Sign up with your email to follow new studies for FTD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain-Delivered gene therapy tested to halt devastating Early-Onset dementia
Disease control Recruiting nowThis early-phase study is testing a one-time gene therapy called AVB-101 for people with a specific genetic form of frontotemporal dementia (FTD-GRN). The therapy is designed to be delivered directly into the brain to restore a missing protein and potentially slow or stop disease…
Matched conditions: FTD
Phase: PHASE1, PHASE2 • Sponsor: AviadoBio Ltd • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Brain injection aims to halt devastating dementia
Disease control Recruiting nowThis early-stage study is testing a one-time gene therapy called PBFT02 for adults with specific genetic forms of frontotemporal dementia (FTD). The therapy is delivered via a single injection into the spinal fluid, aiming to deliver a working copy of a missing or faulty gene to …
Matched conditions: FTD
Phase: PHASE1, PHASE2 • Sponsor: Passage Bio, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Magnetic pulses target brain disease in groundbreaking trial
Disease control Recruiting nowThis study is testing whether a non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) can help control or slow the progression of frontotemporal dementia. Researchers will recruit 120 people, including those with the disease and some …
Matched conditions: FTD
Phase: NA • Sponsor: Università degli Studi di Brescia • Aim: Disease control
Last updated Feb 19, 2026 14:36 UTC
-
Scientists hunt for hidden clues in 1200 patients to unlock brain disease mysteries
Knowledge-focused Recruiting nowThis study aims to better understand diseases like Alzheimer's and Parkinson's by analyzing the genes, proteins, and other molecules in people who have them. Researchers will collect blood and other samples from 1200 participants to look for patterns that could lead to new ways t…
Matched conditions: FTD
Sponsor: Ospedale Policlinico San Martino • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC